42
Participants
Start Date
September 4, 2017
Primary Completion Date
August 19, 2019
Study Completion Date
September 17, 2019
Bupropion
Bupropion XL will be initiated at 150 mg/d on Days 1-4 and increased to 300 mg/d for Days 5-84.
Placebo Oral Tablet
Placebo will be initiated on Day 1 and continue throughout the course of the study.
University of North Carolina at Chapel Hill, Chapel Hill
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
University of North Carolina, Chapel Hill
OTHER